In this study, we further found that YM155, a specific survivin suppressant [24], induced apoptosis of gastric cancer cells, inhibited expansion of gastric CSCs and reduced expression of CSC molecules (CD44 and β-catanin) and suppressed gastric cancer xenograft growth. This evidence concerns the gene CD44 and gastric cancer.